| Burden of diabetic foot ulcers for medicare and private insurers JB Rice, U Desai, AKG Cummings, HG Birnbaum, M Skornicki, ... Diabetes care 37 (3), 651-658, 2014 | 584 | 2014 |
| Burden of venous leg ulcers in the United States JB Rice, U Desai, AKG Cummings, HG Birnbaum, M Skornicki, N Parsons Journal of medical economics 17 (5), 347-356, 2014 | 239 | 2014 |
| Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real … RS Kirsner, ML Sabolinski, NB Parsons, M Skornicki, WA Marston Wound Repair and Regeneration 23 (5), 737-744, 2015 | 81 | 2015 |
| Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers JB Rice, U Desai, L Ristovska, AKG Cummings, HG Birnbaum, ... Journal of Medical Economics 18 (8), 586-595, 2015 | 33 | 2015 |
| Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin’s lymphoma: cost … G Hill, R Barron, K Fust, ME Skornicki, DCA Taylor, MC Weinstein, ... Journal of medical economics 17 (1), 32-42, 2014 | 32 | 2014 |
| Cost-effectiveness of Tdap vaccination of adults aged≥ 65 years in the prevention of pertussis in the US: a dynamic model of disease transmission LJ McGarry, G Krishnarajah, G Hill, C Masseria, M Skornicki, ... PloS one 9 (1), e72723, 2014 | 31 | 2014 |
| An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: does … J Shafrin, M Skornicki, M Brauer, J Villeneuve, M Lees, N Hertel, ... Health Policy 122 (6), 607-613, 2018 | 24 | 2018 |
| Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox–Gastaut syndrome KM Clements, M Skornicki, AK O'Sullivan Epilepsy & Behavior 29 (1), 184-189, 2013 | 21 | 2013 |
| Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly LJ McGarry, G Krishnarajah, G Hill, M Skornicki, N Pruttivarasin, ... PloS one 8 (9), e67260, 2013 | 21 | 2013 |
| Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome M Skornicki, KM Clements, AK O’Sullivan Journal of Managed Care Pharmacy 20 (4), 400-406, 2014 | 18 | 2014 |
| The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a … I Kraus, ML Sabolinski, M Skornicki, NB Parsons Wounds: a Compendium of Clinical Research and Practice 29 (5), 125-132, 2017 | 17 | 2017 |
| Comparative effectiveness of a bioengineered living cellular construct and cryopreserved cadaveric skin allograft for the treatment of venous leg ulcers in a real-world setting T Treadwell, ML Sabolinski, M Skornicki, NB Parsons Advances in Wound Care 7 (3), 69-76, 2018 | 14 | 2018 |
| Use of net monetary benefit analysis to comprehensively understand the value of innovative treatments J Shafrin, SG May, M Skornicki, J Hathway, R Macaulay, J Villeneuve, ... Value in Health 19 (7), A731, 2016 | 9 | 2016 |
| Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study. RH Fitzgerald, ML Sabolinski, M Skornicki Wound Management & Prevention 65 (9), 26-34, 2019 | 7 | 2019 |
| Medical, drug, and work-loss costs of venous leg ulcers JB Rice, U Desai, AK Cummings, HG Birnbaum, M Skornicki, N Parsons Value in Health 16 (3), A73, 2013 | 6 | 2013 |
| Clinical burden of concomitant joint disease in psoriasis: a US-Linked claims and electronic health records database analysis M Skornicki, P Prince, R Suruki, E Lee, A Louder Advances in Therapy 38, 2458-2471, 2021 | 5 | 2021 |
| Expanding cost-effectiveness analysis to all of health care: comparisons between CEAs on pharmaceuticals and medical/surgical procedures J Baumgardner, M Brauer, M Skornicki, P Neumann Los Angeles, 2018 | 5 | 2018 |
| Economic Burden of Joint Disease in Psoriasis: US Claims Analysis. P Prince, M Skornicki, R Suruki, E Lee, A Louder American Journal of Managed Care 27 (12), 2021 | 4 | 2021 |
| Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014; 37: 651-658 SJ RICE, U Desai, AKG Cummings, HG Birnbaum, M Skornicki, ... Diabetes care 37 (9), 2014 | 4 | 2014 |
| Medical, Drug, and Work-Loss Costs of Diabetic Foot Ulcers JB Rice, U Desai, AK Cummings, HG Birnbaum, M Skornicki, N Parsons Value in Health 16 (3), A12, 2013 | 4 | 2013 |
